Dialysis vein mystery: researchers hunt for clues to prevent blockages
NCT ID NCT01693263
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study follows 96 people with end-stage kidney disease who need a brachiocephalic fistula for dialysis. Researchers collect data from exams, blood tests, and imaging to track changes in the vein over time. The goal is to learn what causes cephalic arch stenosis, a common narrowing that can make dialysis difficult. Findings may help improve how fistulas are created and managed.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this research could identify causes of vein narrowing in dialysis patients, leading to better fistula designs and fewer complications.
- What could go wrong
- This is an observational study with only 96 participants, so findings may not apply to all patients. It does not test a new treatment directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRACHIOCEPHALIC FISTULA (BCF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Less dialysis, more kidney? study tests gentler start for kidney failure patients
- Pill vs. machine: which fixes acid imbalance better for dialysis patients?
- Dialysis filter showdown: could the right membrane tame inflammation?
- Heat pack before dialysis needle may ease pain, study tests best timing
- Diabetes drug semaglutide tested in dialysis patients for safety
- Lab-Made blood vessel could free dialysis patients from catheters